Description
Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Dataset | CSV | Open resource | |
| Dataset | CSV | Open resource | |
| Dataset | XML | Open resource | |
| Supporting Document | HTML | Open resource | |
| Supporting Document | HTML | Open resource |